Details for New Drug Application (NDA): 216990
NDA 216990 describes VENXXIVA, which is a drug marketed by Torrent and is included in one NDA. It is available from two suppliers. Additional details are available on the VENXXIVA profile page.
The generic ingredient in VENXXIVA is tiopronin. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
The generic ingredient in VENXXIVA is tiopronin. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
Pharmacology for NDA: 216990
| Mechanism of Action | Cystine Disulfide Reduction |
Suppliers and Packaging for NDA: 216990
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VENXXIVA | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990 | ANDA | Torrent Pharmaceuticals Limited | 13668-691 | 13668-691-03 | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-691-03) |
| VENXXIVA | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990 | ANDA | Torrent Pharmaceuticals Limited | 13668-692 | 13668-692-90 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-692-90) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 100MG | ||||
| Approval Date: | Jan 30, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 300MG | ||||
| Approval Date: | Jan 30, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
